University Of Notre Dame Du Lac Rhythm Pharmaceuticals, Inc. Transaction History

University Of Notre Dame Du Lac

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$13.16 - $22.9 $584,172 - $1.02 Million	-44,390 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$19.53 - $25.5 $7,636 - $9,970	-391 Reduced 0.87%	44,390 $1.02 Million
Q3 2019 Nov 13, 2019	SELL	$18.62 - $24.51 $1.75 Million - $2.3 Million	-93,916 Reduced 67.71%	44,781 $967,000
Q2 2019 Aug 14, 2019	BUY	$21.11 - $28.48 $2.93 Million - $3.95 Million	138,697 New	138,697 $3.05 Million

178

69.1M

467K

224K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.86B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

Stay updated on University Of Notre Dame Du Lac with notifications on news.